Literature DB >> 2795078

A prospective audit of the use and costs of myelography in a regional neuroscience unit.

P A Sandercock1, M A Roberts, L D Blumhardt.   

Abstract

A consecutive series of 397 myelograms performed in 385 patients over a six month period at the Mersey Regional Neurosciences Unit is reported. The reasons for performing the myelogram were to identify the cause of a radicular lesion in 54% of patients, a chronic spinal cord lesion in 30%, an acute cord lesion in 9%, suspected disease at the level of the foramen magnum 6%, and for a variety of other conditions in 8%. For the 385 patients undergoing a myelogram in the study period, the median interval from admission to request, request to myelography and from myelography to discharge was nought, one and three days respectively. The proportion of patients submitted to myelography by individual consultants ranged from 7% to 28%. There was a two-fold variation in the delays in the time to requesting and performing myelograms. There was room for improvement in the clinical information supplied on the myelography request form. The role of ancillary investigations and their effect on myelography was unclear. Only 16 of the patients with suspected cord disease had visual evoked responses performed before myelography. Five of them had myelography after an abnormal result. The estimated annual direct cost of myelography in the unit was at least 486,000 pounds. Reorganisation might have yielded hypothetical "savings" of between 30,000 pounds (6%) and 155,000 pounds (32%), though in practical terms these "savings" represented resources which might have been freed for use in other higher priority clinical problems within the unit, rather than true reductions in monetary cost.

Entities:  

Mesh:

Year:  1989        PMID: 2795078      PMCID: PMC1031744          DOI: 10.1136/jnnp.52.9.1078

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  Availability of computed tomography of the brain in the United Kingdom.

Authors:  R L Hewer; V A Wood
Journal:  BMJ       Date:  1989-05-06

2.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes.

Authors:  D H Miller; W I McDonald; L D Blumhardt; G H du Boulay; A M Halliday; G Johnson; B E Kendall; D P Kingsley; D G MacManus; I F Moseley
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

3.  Experiences at the new magnetic resonance imaging centre at Bristol.

Authors:  J L Thomson
Journal:  Br J Radiol       Date:  1989-02       Impact factor: 3.039

4.  A survey of surgical management of lumbar disc prolapse in the United Kingdom and Erie.

Authors:  D Le Vay
Journal:  Lancet       Date:  1967-06-03       Impact factor: 79.321

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  Clinical indications for computer-assisted myelography.

Authors:  D L Barrow; J H Wood; J C Hoffman
Journal:  Neurosurgery       Date:  1983-01       Impact factor: 4.654

7.  Value of visual evoked response and oligoclonal bands in cerebrospinal fluid in diagnosis of spinal multiple sclerosis.

Authors:  P A Kempster; R Iansek; J I Balla; P M Dennis; B Biegler
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

8.  Magnetic resonance imaging of spinal cord syndromes.

Authors:  H Gräfin von Einsiedel; R Stepan
Journal:  Eur J Radiol       Date:  1985-05       Impact factor: 3.528

  8 in total
  3 in total

1.  Value of a programmed investigation unit: an audit study.

Authors:  A P Moore; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  Neurology in the market place.

Authors:  I R Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Steps towards cost-benefit analysis of regional neurosurgical care.

Authors:  J D Pickard; S Bailey; H Sanderson; M Rees; J S Garfield
Journal:  BMJ       Date:  1990-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.